Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel
Teva's Deal for Mylan Shows Corporate Israel's M&A Hunger - WSJ
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva firing 350 employees from Israeli production facility | Ctech
Teva to pay $225 million to settle cholesterol drug price-fixing charges | The Times of Israel
Teva boss hits out at opioid lawsuits
Teva Pharmaceuticals found liable for role in New York opioid epidemic - UPI.com
Teva Lifts Outlook With Drug Production Mostly Unaffected by War - Bloomberg
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Pharmaceutical to Nominate Four New Directors - WSJ
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Faces New Class Action—But Could It Afford Another Settlement? | Connecticut Law Tribune
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
An Israeli pharma champion sickens
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva says Israel-Hamas war not hurting production, eyes growth in 2024 | Reuters
Israeli Pension Fund Manager Leads Class Action Against Teva Pharmaceuticals Over Price-Hike and Opioid Scandals | Courthouse News Service
Teva Restructuring Coming Together, Rebuilding Confidence in the Company | BioSpace
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
With 3K-plus Teva layoffs slated in Israel and labor protests brewing, top exec steps aside | Fierce Pharma
Israel targets Teva over MS drug royalties
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs
